Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.6
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
 3 Months Ended 6 Months Ended 116 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
COSTS AND EXPENSES:          
Research and development $ 1,314,623 $ 961,953 $ 2,642,937 $ 1,433,356 $ 23,447,976
General and administrative 896,881 796,714 1,894,552 928,440 11,557,163
Merger costs 0 495,773 0 746,207 799,133
Total costs and expenses 2,211,504 2,254,440 4,537,489 3,108,003 35,804,272
LOSS FROM OPERATIONS (2,211,504) (2,254,440) (4,537,489) (3,108,003) (35,804,272)
OTHER INCOME (EXPENSE):          
Grant income 0 0 0 44,479 244,479
Loss on derivative warrants (17,234) (70,393) (46,080) (70,393) (58,238)
Interest expense, net (2,073) (270,378) (4,145) (426,546) (451,270)
Other income 0 0 0 0 1,161
Total other expense, net (19,307) (340,771) (50,225) (452,460) (263,868)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS $ (2,230,811) $ (2,595,211) $ (4,587,714) $ (3,560,463) $ (36,068,140)
BASIC AND DILUTED NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER COMMON SHARE (in dollars per share) $ (0.06) $ (0.10) $ (0.12) $ (0.18) $ (2.90)
SHARES USED IN COMPUTING BASIC AND DILUTED NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER COMMON SHARE (in shares) 38,598,586 25,743,781 37,754,402 19,317,642 12,453,597